Top Markets
#1 PulseChain PulseChain +45.01%
#2 Glidr Glidr +20.14%
#3 Fake World Assets Fake World Assets +9.76%
#4 Ergo Ergo +9.25%
#5 eCash eCash +8.85%
#6 DeFi Kingdoms DeFi Kingdoms +8.68%
#7 Ribbita by Virtuals Ribbita by Virtuals +8.32%
#8 Meteora Meteora +8.28%
#9 Verus Coin Verus Coin +7.70%
#10 Cash Cat Cash Cat +7.22%
Coin of the day
PulseChain PulseChain
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc.

AGE
Classement en actions #28237
AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to... AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to pioneering and commercializing groundbreaking therapies that address human aging and degenerative conditions. The company's developmental pipeline features several promising cell-based therapeutic candidates: AGEX-BAT1: A cell therapy designed to manage various age-related metabolic disorders, including adult-onset Type II diabetes and obesity. AGEX-VASC1: A cell-based approach aimed at re-establishing vital vascular support in aged ischemic tissues, which could be relevant for conditions such as peripheral vascular disease and ischemic heart disease. Beyond cell therapies, AgeX is also exploring other modalities: Its primary drug candidate in the discovery phase is AGEX-iTR1547, a drug formulation focused on achieving scarless wound repair. For induced tissue regeneration, its leading biologic candidate is AGEX-iTR1550, which leverages gene delivery technology. Furthermore, AgeX maintains a research collaboration with the University of California at Irvine, jointly working to develop cellular therapies for various neurological disorders. Founded in 2017, AgeX Therapeutics, Inc. maintains its headquarters in Alameda, California.
Prix de l'action
$11.10
Dernière synchronisation: 2024-03-26
Capitalisation boursière
$27.76M
Changement (1 jour)
-11.90%
Changement (1 an)
0.00%
Pays
US
Échange AgeX Therapeutics, Inc. (AGE)

Catégorie

Healthcare
Le prix AGE avec la capitalisation boursière de B
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.
AGE
$11.10
Capitalisation boursière de AgeX Therapeutics, Inc.(AGE)
Capitalisation boursière: $27.76M
En August 2026, AgeX Therapeutics, Inc. a une capitalisation boursière de $27.76M. Cela fait de AgeX Therapeutics, Inc. la 28237th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de AgeX Therapeutics, Inc. du 2018 au 2026
AGE par rapport au top 5 des plus populaires stocks
Prix pour AGE L’actif B La capitalisation boursière de B Résultats
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.
$2,119,574 $27.76M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.301T +19,095,157.51%
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.
$1,852,871 $27.76M
Apple Inc. Apple Inc.
AAPL
$4.634T +16,692,431.23%
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.
$1,656,588 $27.76M
Alphabet Inc. Alphabet Inc.
GOOG
$4.143T +14,924,113.41%
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.
$1,435,225 $27.76M
Microsoft Corporation Microsoft Corporation
MSFT
$3.589T +12,929,857.38%
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.
$1,142,363 $27.76M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.857T +10,291,454.14%